125 related articles for article (PubMed ID: 30829272)
21. Loss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in vietnamese breast cancer patients.
Truong PK; Lao TD; Doan TP; Le TA
Asian Pac J Cancer Prev; 2015; 16(6):2209-13. PubMed ID: 25824739
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
23. The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation.
Masood S; El-Gabry E; Zhang C; Wang Z
Diagn Cytopathol; 2016 Aug; 44(8):670-5. PubMed ID: 27229911
[TBL] [Abstract][Full Text] [Related]
24. Molecular monitoring by CDKN2A/p16INK4A and RB1 gene methylation in breast cancer.
Queiroz LF; Silva MSDME; Rosman FC; Rosas SLB; Souza HSP; Carvalho MDGDC
Rev Assoc Med Bras (1992); 2024; 70(4):e20231358. PubMed ID: 38716944
[TBL] [Abstract][Full Text] [Related]
25. DFNA5 promoter methylation a marker for breast tumorigenesis.
Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G
Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
27. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
28. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
[TBL] [Abstract][Full Text] [Related]
30. BCL-6 oncoprotein in breast cancer: loss of expression in disease progression.
Pinto AE; André S; Silva G; Vieira S; Santos AC; Dias S; Soares J
Pathobiology; 2009; 76(5):235-42. PubMed ID: 19816083
[TBL] [Abstract][Full Text] [Related]
31. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.
Van der Auwera I; Bovie C; Svensson C; Trinh XB; Limame R; van Dam P; van Laere SJ; van Marck EA; Dirix LY; Vermeulen PB
BMC Cancer; 2010 Mar; 10():97. PubMed ID: 20226036
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
33. High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer.
Thakur GK; Sharma T; Krishna Latha T; Banerjee BD; Shah HK; Guleria K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2923-2928. PubMed ID: 31653136
[TBL] [Abstract][Full Text] [Related]
34. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of the association between APC promoter methylation and breast cancer.
He K; Zhang L; Long X
Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268
[TBL] [Abstract][Full Text] [Related]
36. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
37. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
38. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]